Paper - WANFANG MED ONLINE

You Position: Home > Paper

Reduced Expression of the LRP16 Gene in Mouse Insulinoma (MIN6) Cells Exerts Multiple Effects on Insulin Content, Proliferation and Apoptosis

( views:141, downloads:0 )

Author:: No author available

Journal Title:: Journal of Huazhong University of Science and Technology(Medical Science)

Issue:: 2

DOI:: 10.1007/s11596-012-0034-6

Key Word:: LRP16;MIN6;insulin;Akt signaling;proliferation;apoptosis

Abstract： This study assessed the effects of leukemia-related protein 16 (LRP16) on the regulation of pancreatic functions in mouse insulinoma (MIN6) cells.Cells with down-regulated expression of LRP16 were obtained by a shRNA interference strategy.Insulin content and glucose-stimulated insulin secretion (GSIS) were examined by radioimmunoassay.Western blotting was applied to detect protein expression.Glucose-stimulated sub-cellular localization of PDX-1 was immunocytochemically determined.Cell proliferation and apoptosis were detected by flow cytometry.Our results showed that LRP16 regulated insulin content in MIN6 cells by controlling expression of insulin and insulin transcription factors.LRP16 gene silence in MIN6 cells led to reduced cell proliferation and increased apoptosis.The observation of phosphorylation of serine-473 Akt and the localization of PDX-1 to the nucleus under glucose-stimulation exhibited that LRP16 was a component mediating Akt signaling in MIN6 cells.These results suggest that LRP16 plays a key role in maintaining pancreatic β-cell functions and may help us to understand the protective effects of estrogen on the functions of pancreatic β-cells.

Reference

[1]Walker MD,Glick E,Leshkowitz D.Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter.[J].2000,275(3).
[2]Gleichmann H,Wang Z.GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.[J].1998,47(1).
[3]McKinnon CM,Cragg H,Felton Edkins-ZA,etc.Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells.[J].1999,274(2).
[4]Tsutsui T,Hesabi B,Moons DS,etc.Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.[J].1999,19(10).
[5]Suwattanee, Kooptiwut,Namoiy, Semprasert,Supornpim, Chearskul.Estrogen increases glucose-induced insulin secretion from mouse pancreatic islets cultured in a prolonged high glucose condition.[J].2007,90(5).
[6]Ozcan S,Vanderford NL,Andrali SS.Glucose induces MafA expression in pancreatic beta cell lines via the hexosamine biosynthetic pathway.[J].2007,282(3).
[7]Kitamura Y,Biggs WH 3rd,Wright CV,etc.The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.[J].2002,110(12).
[8]Lawrence M,Cobb MH,McGlynn K,etc.The protein kinases ERK1/2 and their roles in pancreatic beta cells.[J].2008,192(1).
[9]Alonso Magdalena P,Soriano S,Gassner B,etc.Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor.[J].2009,23(12).
[10]Poitout V,Hays LB,Hagman DK,etc.Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans[J].2005,280(37).
[11]E, Van Schaftingen,M, Detheux,M, Veiga da Cunha.Short-term control of glucokinase activity: role of a regulatory protein.[J].1994,8(6).
[12]Paloma, Alonso-Magdalena,Ana B, Ropero,M Pilar, Carrera,etc.Pancreatic insulin content regulation by the estrogen receptor ER alpha.[J].2008,3(4).
[13]Dubus P,Barbacid M,Galbreath EJ,etc.Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia.[J].1999,22(1).
[14]Juehu Wang,Luping Shen,Habiba Najafi.Regulation of insulin preRNA splicing by glucose[J].1997,94(9).
[15]Rochira V,Spaggiari A,Carani C,etc.Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men.[J].2002,193(1).
[16]Le Lay J,Stein R.Involvement of PDX-1 in activation of human insulin gene transcription.[J].2006,188(2).
[17]Liu S,Mauvais Jarvis F.Minireview: Estrogenic protection of beta-cell failure in metabolic diseases.[J].2010,151(3).
[18]Cozar Castellano I,Garcia Ocana A,Takane KK,etc.Molecular control of cell cycle progression in the pancreatic beta-cell.[J].2006,27(4).
[19]Newton K,Brown RH Jr,Glover LE,etc.Dysferlin overexpression in skeletal muscle produces a progressive myopathy.[J].2010,67(3).
[20]Stahlhut S,Wen W,Permutt MA,etc.Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia.[J].2001,108(11).
[21]Ciemerych MA,Long SY,Sicinski P,etc.Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth[J].2005,25(9).
[22]I F, Godsland.Oestrogens and insulin secretion.[J].2005,48(11).
[23]Becker TC,Mirmira RG,Francis J,etc.Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1 - Application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes[J].2005,280(17).
[24]L, Elghazi,L, Rachdi,A J, Weiss,etc.Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway.[J].2007,9 Suppl 2.
[25]Lawrence MC,McGlynn K,Park BH,etc.ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter[J].2005,280(29).
[26]Ortega CS,Mauvais-Jarvis F,Simpson ER,etc.Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice[J].2006,103(24).
[27]R Keith, Campbell.Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies.[J].1900,49 Suppl 1.
[28]Sachdeva MM,Stoffers DA.Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion.[J].2009,23(6).
[29]Bernardo AS,Hay CW,Docherty K.Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell.[J].2008,294(1).
[30]Pal M.Medicinal chemistry approaches for glucokinase activation to treat type 2 diabetes.[J].2009,16(29).
[31]Bernal Mizrachi E,Elghazi L.Akt and PTEN: beta-cell mass and pancreas plasticity.[J].2009,20(5).
[32]S, Efrat,M, Tal,H F, Lodish.The pancreatic beta-cell glucose sensor.[J].1994,19(12).